Novo Nordisk Inks $1.1B Deal For German Pharma Biz

By Josh White · March 25, 2024, 5:56 PM GMT

Danish pharmaceutical giant Novo Nordisk A/S said Monday it has signed a deal to acquire Cardior Pharmaceuticals of Germany for just over €1 billion ($1.1 billion) to widen its focus on...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Lawyers Adapt To Crop Of New FDA Pilots No Photo Available

Yeji Jesse Lee

A slew of new FDA pilot programs is forcing life science attorneys to adjust to a new reality of programs that shed bureaucratic proce... (more story)

Health Hires: Goodwin Partner Joins Incyte, Gilead GC Exits No Photo Available

Gianna Ferrarin

Law360 Healthcare Authority looks at the week's most notable personnel changes in the healthcare and life sciences industries.

Defamation Litigation Roundup: FDA, Lively, Alexander Bros. No Photo Available

Theresa Schliep

In this month's review of defamation fights, Law360 highlights a pharmaceutical company's suit against a former U.S. Food and Drug Adm... (more story)